 |
|
(reh-SEN-tin)
| | A substance being studied in the treatment of some types of cancer. Recentin may prevent the growth of new blood vessels that tumors need to grow and may kill cancer cells. It is a type of antiangiogenesis agent and a type of vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor. Also called AZD2171 and cediranib. |
| Previous Definitions: | RAV12, ravuconazole, RBC, rebeccamycin, rebeccamycin analog | | Next Definitions: | receptor, recombinant, recombinant adenovirus-p53, recombinant fowlpox-CEA-MUC-1-TRICOM vaccine, recombinant fowlpox-TRICOM vaccine |
|
|
